Skip to Content

Sandoz 663 Sandoz 663 (Cefdinir 300 mg)

Pill with imprint Sandoz 663 Sandoz 663 is Blue, Capsule-shape and has been identified as Cefdinir 300 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Cefdinir is used in the treatment of sinusitis; bronchitis; pneumonia; otitis media; skin or soft tissue infection (and more), and belongs to the drug class third generation cephalosporins. There is no proven risk in humans during pregnancy. Cefdinir 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for Sandoz 663 Sandoz 663

Cefdinir 300 mg Sandoz 663 Sandoz 663
Cefdinir 300 mg Sandoz 663 Sandoz 663
Cefdinir 300 mg Sandoz 663 Sandoz 663


Sandoz 663 Sandoz 663
300 mg
22.00 mm
Prescription only
Drug Class:
Third generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Sandoz Pharmaceuticals Inc.
Inactive Ingredients:
carboxymethylcellulose calcium
FD&C Blue No. 2
magnesium stearate
silicon dioxide
titanium dioxide
Note: Inactive ingredients may vary.

Other Labelers / Repackagers:

NDC CodeLabeler / Repackager
67253-0011 DAVA Pharmaceuticals, Inc.

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.